Literature DB >> 30187078

[Diagnostic imaging of drug-induced osteonecrosis of the jaw].

V Hingst1, M-A Weber2.   

Abstract

Drug-induced osteonecrosis of the jaw represents a relatively new, multifactor-induced disease. Diseases with increased bone resorption are widely treated with antiresorptive drugs. Due to the active bone metabolism, especially in the lower jaw, it can lead to osteonecrosis if the barrier function in the oral cavity is impaired and it may be complicated by systemic comorbidities depending on duration, intensity, and application of antiresorptive therapy. Due to the special influence of these changes on the quality of life and because of the complex therapy management, the early detection and determination of the extent of the lesion(s) by imaging is of particular importance. The orthopantomography (panoramic radiography) of the jaw provides a good basic examination, especially for the detection of dental causes as a possible differential diagnosis. Three-dimensional imaging techniques such as computed tomography and in particular magnetic resonance imaging can detect bone changes much more sensitively and detect the manifestation of complex pathologies in higher stages of disease.

Entities:  

Keywords:  Antiresorptive drugs; Determination of extent; Early detection of disease; Imaging; Jaw diseases

Mesh:

Substances:

Year:  2018        PMID: 30187078     DOI: 10.1007/s00117-018-0443-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  15 in total

1.  Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.

Authors:  Matthew Hutchinson; Felice O'Ryan; Vicente Chavez; Phenius V Lathon; Gabriela Sanchez; David C Hatcher; A Thomas Indresano; Joan C Lo
Journal:  J Oral Maxillofac Surg       Date:  2010-09       Impact factor: 1.895

2.  Imaging features of medicine-related osteonecrosis of the jaws: comparison between panoramic radiography and computed tomography.

Authors:  Yuxing Guo; Diancan Wang; Yang Wang; Xin Peng; Chuanbin Guo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2016-04-22

Review 3.  Skull base osteomyelitis and bisphosphonate use in multiple myeloma: report of two cases and literature review.

Authors:  Jeffrey M Phillips; Joel D Thibodeaux; Cherie-Ann Nathan
Journal:  Laryngoscope       Date:  2010       Impact factor: 3.325

Review 4.  [Bisphosphonate-associated osteonecrosis of the jaw].

Authors:  S Koy; M Schubert; J Koy; M Ney; G Lauer; R Sabatowski
Journal:  Schmerz       Date:  2015-04       Impact factor: 1.107

5.  Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.

Authors:  Nathaniel S Treister; Bernard Friedland; Sook-Bin Woo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03-29

6.  MRI of mandibular osteonecrosis secondary to bisphosphonates.

Authors:  Luis García-Ferrer; Jose V Bagán; Vicente Martínez-Sanjuan; Sergio Hernandez-Bazan; Raquel García; Yolanda Jiménez-Soriano; Vicente Hervas
Journal:  AJR Am J Roentgenol       Date:  2008-04       Impact factor: 3.959

7.  [Bilateral bisphosphonate-associated osteonecrosis of the external ear canal : a rare case].

Authors:  F Bast; H Fuss; T Schrom
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

8.  Whole-body-MR-diffusion weighted imaging in oncology.

Authors:  T Wilhelm; B Stieltjes; H P Schlemmer
Journal:  Rofo       Date:  2013-10

Review 9.  Bisphosphonate-induced osteonecrosis of the ear canal: our experience and a review of the literature.

Authors:  L McCadden; C G Leonard; W J Primrose
Journal:  J Laryngol Otol       Date:  2018-02-28       Impact factor: 1.469

Review 10.  Bisphophonates related osteonecrosis of the jaw.

Authors:  Swati Gupta; Hemant Gupta; Devendra Mandhyan; Sanjeev Srivastava
Journal:  Natl J Maxillofac Surg       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.